5-Oxo-ETE analogs and the proliferation of cancer cells

被引:54
作者
O'Flaherty, JT [1 ]
Rogers, LC
Paumi, CM
Hantgan, RR
Thomas, LR
Clay, CE
High, K
Chen, YQ
Willingham, MC
Smitherman, PK
Kute, TE
Rao, A
Cramer, SD
Morrow, CS
机构
[1] Wake Forest Univ, Med Ctr, Infect Dis Sect, Dept Internal Med, Winston Salem, NC 27156 USA
[2] Wake Forest Univ, Med Ctr, Dept Biochem, Winston Salem, NC 27103 USA
[3] Wake Forest Univ, Med Ctr, Dept Canc Biol, Winston Salem, NC 27109 USA
[4] Wake Forest Univ, Med Ctr, Dept Pathol, Winston Salem, NC 27109 USA
[5] Wake Forest Univ, Med Ctr, Dept Internal Med, Gastroenterol Sect, Winston Salem, NC 27109 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2005年 / 1736卷 / 03期
关键词
5-Oxo-ETE; 5-HETE; cancer cell; proliferation; apoptosis; PPAR;
D O I
10.1016/j.bbalip.2005.08.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MDA-MB-231, MCF7, and SKOV3 cancer cells, but not HEK-293 cells, expressed mRNA for the leukocyte G protein-coupled 5-oxo-eicosatetracnoate (ETE) OXE receptor. 5-Oxo-ETE, 5-oxo-15-OH-ETE, and 5-HETE stimulated the cancer cell lines but not HEK-293 cells to mount pertussis toxin-sensitive proliferation responses. Their potencies in eliciting this response were similar to their known potencies in activating leukocytes and OXE receptor-transfected cells. However, high concentrations of 5-oxo-ETE and 5-oxo-15-OHETE, but not 5-HETE, arrested growth and caused apoptosis in all four cell lines; these responses were pertussis toxin-resistant. The same high concentrations of the oxo-ETEs but again not 5-HETE also activated peroxisome proliferator-activated receptor (PPAR)-gamma. Pharmacological studies indicated that this activation did not mediate their effects on proliferation. These results are the first to implicate the OXE receptor in malignant cell growth and to show that 5-oxo-ETEs activate cell death programs as well as PPAR-gamma independently of this receptor. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 40 条
[1]   Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling [J].
Avis, IM ;
Jett, M ;
Boyle, T ;
Vos, MD ;
Moody, T ;
Treston, AM ;
Martinez, A ;
Mulshine, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :806-813
[2]   Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apopiosis in human and rat hepatoma cell lines [J].
Bae, MA ;
Rhee, H ;
Song, BJ .
TOXICOLOGY LETTERS, 2003, 139 (01) :67-75
[3]   Alterations of peroxisome proliferator-activated receptor δ activity affect fatty acid-controlled adipose differentiation [J].
Bastie, C ;
Luquet, S ;
Holst, D ;
Jehl-Pietri, C ;
Grimaldi, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38768-38773
[4]   A novel glutathione containing eicosanoid (FOG7) chemotactic for human granulocytes [J].
Bowers, RC ;
Hevko, J ;
Henson, PM ;
Murphy, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :29931-29934
[5]   15-deoxy-Δ 12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit [J].
Cernuda-Morollón, E ;
Pineda-Molina, E ;
Cañada, FJ ;
Pérez-Sala, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35530-35536
[6]   Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway [J].
Chen, Y ;
Morrow, JD ;
Roberts, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10863-10868
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis does not require PPARγ in breast cancer cells [J].
Clay, CE ;
Monjazeb, A ;
Thorburn, J ;
Chilton, FH ;
High, KP .
JOURNAL OF LIPID RESEARCH, 2002, 43 (11) :1818-1828
[9]   Human colorectal cancer cells efficiently conjugate the cyclopentenone prostaglandin, prostaglandin J2, to glutathione [J].
Cox, B ;
Murphey, LJ ;
Zackert, WE ;
Chinery, R ;
Graves-Deal, R ;
Boutaud, O ;
Oates, JA ;
Coffey, RJ ;
Morrow, JD .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1584 (01) :37-45
[10]  
Cuendet M, 2000, Drug Metabol Drug Interact, V17, P109